206 related articles for article (PubMed ID: 30304524)
1. Homozygosity for a mutation affecting the catalytic domain of tyrosyl-tRNA synthetase (YARS) causes multisystem disease.
Williams KB; Brigatti KW; Puffenberger EG; Gonzaga-Jauregui C; Griffin LB; Martinez ED; Wenger OK; Yoder MA; Kandula VVR; Fox MD; Demczko MM; Poskitt L; Furuya KN; Reid JG; Overton JD; Baras A; Miles L; Radhakrishnan K; Carson VJ; Antonellis A; Jinks RN; Strauss KA
Hum Mol Genet; 2019 Feb; 28(4):525-538. PubMed ID: 30304524
[TBL] [Abstract][Full Text] [Related]
2. A novel multisystem disease associated with recessive mutations in the tyrosyl-tRNA synthetase (YARS) gene.
Nowaczyk MJ; Huang L; Tarnopolsky M; Schwartzentruber J; Majewski J; Bulman DE; ; Hartley T; Boycott KM
Am J Med Genet A; 2017 Jan; 173(1):126-134. PubMed ID: 27633801
[TBL] [Abstract][Full Text] [Related]
3. A Novel Homozygous Missense Mutation in the
Zeiad RKHM; Ferren EC; Young DD; De Lancy SJ; Dedousis D; Schillaci LA; Redline RW; Saab ST; Crespo M; Bhatti TR; Ackermann AM; Bedoyan JK; Wood JR
J Endocr Soc; 2021 Feb; 5(2):bvaa196. PubMed ID: 33490854
[TBL] [Abstract][Full Text] [Related]
4. The recurrent missense mutation p.(Arg367Trp) in YARS1 causes a distinct neurodevelopmental phenotype.
Averdunk L; Sticht H; Surowy H; Lüdecke HJ; Koch-Hogrebe M; Alsaif HS; Kahrizi K; Alzaidan H; Alawam BS; Tohary M; Kraus C; Endele S; Wadman E; Kaplan JD; Efthymiou S; Najmabadi H; Reis A; Alkuraya FS; Wieczorek D
J Mol Med (Berl); 2021 Dec; 99(12):1755-1768. PubMed ID: 34536092
[TBL] [Abstract][Full Text] [Related]
5. Novel partial loss-of-function variants in the tyrosyl-tRNA synthetase 1 (YARS1) gene involved in multisystem disease.
Estève C; Roman C; DeLeusse C; Baravalle M; Bertaux K; Blanc F; Bourgeois P; Bresson V; Cano A; Coste ME; Delteil C; Lacoste C; Loosveld M; De Paula AM; Monnier AS; Secq V; Levy N; Badens C; Fabre A
Eur J Med Genet; 2021 Oct; 64(10):104294. PubMed ID: 34352414
[TBL] [Abstract][Full Text] [Related]
6. Disrupted function and axonal distribution of mutant tyrosyl-tRNA synthetase in dominant intermediate Charcot-Marie-Tooth neuropathy.
Jordanova A; Irobi J; Thomas FP; Van Dijck P; Meerschaert K; Dewil M; Dierick I; Jacobs A; De Vriendt E; Guergueltcheva V; Rao CV; Tournev I; Gondim FA; D'Hooghe M; Van Gerwen V; Callaerts P; Van Den Bosch L; Timmermans JP; Robberecht W; Gettemans J; Thevelein JM; De Jonghe P; Kremensky I; Timmerman V
Nat Genet; 2006 Feb; 38(2):197-202. PubMed ID: 16429158
[TBL] [Abstract][Full Text] [Related]
7. A recurrent missense variant in HARS2 results in variable sensorineural hearing loss in three unrelated families.
Demain LAM; Gerkes EH; Smith RJH; Molina-Ramirez LP; O'Keefe RT; Newman WG
J Hum Genet; 2020 Mar; 65(3):305-311. PubMed ID: 31827252
[TBL] [Abstract][Full Text] [Related]
8. Cysteinyl-tRNA Synthetase Mutations Cause a Multi-System, Recessive Disease That Includes Microcephaly, Developmental Delay, and Brittle Hair and Nails.
Kuo ME; Theil AF; Kievit A; Malicdan MC; Introne WJ; Christian T; Verheijen FW; Smith DEC; Mendes MI; Hussaarts-Odijk L; van der Meijden E; van Slegtenhorst M; Wilke M; Vermeulen W; Raams A; Groden C; Shimada S; Meyer-Schuman R; Hou YM; Gahl WA; Antonellis A; Salomons GS; Mancini GMS
Am J Hum Genet; 2019 Mar; 104(3):520-529. PubMed ID: 30824121
[TBL] [Abstract][Full Text] [Related]
9. The exome sequencing identified the mutation in YARS2 encoding the mitochondrial tyrosyl-tRNA synthetase as a nuclear modifier for the phenotypic manifestation of Leber's hereditary optic neuropathy-associated mitochondrial DNA mutation.
Jiang P; Jin X; Peng Y; Wang M; Liu H; Liu X; Zhang Z; Ji Y; Zhang J; Liang M; Zhao F; Sun YH; Zhang M; Zhou X; Chen Y; Mo JQ; Huang T; Qu J; Guan MX
Hum Mol Genet; 2016 Feb; 25(3):584-96. PubMed ID: 26647310
[TBL] [Abstract][Full Text] [Related]
10. CMT-associated mutations in glycyl- and tyrosyl-tRNA synthetases exhibit similar pattern of toxicity and share common genetic modifiers in Drosophila.
Ermanoska B; Motley WW; Leitão-Gonçalves R; Asselbergh B; Lee LH; De Rijk P; Sleegers K; Ooms T; Godenschwege TA; Timmerman V; Fischbeck KH; Jordanova A
Neurobiol Dis; 2014 Aug; 68():180-9. PubMed ID: 24807208
[TBL] [Abstract][Full Text] [Related]
11. Drosophila as a platform to predict the pathogenicity of novel aminoacyl-tRNA synthetase mutations in CMT.
Leitão-Gonçalves R; Ermanoska B; Jacobs A; De Vriendt E; Timmerman V; Lupski JR; Callaerts P; Jordanova A
Amino Acids; 2012 May; 42(5):1661-8. PubMed ID: 21384131
[TBL] [Abstract][Full Text] [Related]
12. Mutations in LARS2, encoding mitochondrial leucyl-tRNA synthetase, lead to premature ovarian failure and hearing loss in Perrault syndrome.
Pierce SB; Gersak K; Michaelson-Cohen R; Walsh T; Lee MK; Malach D; Klevit RE; King MC; Levy-Lahad E
Am J Hum Genet; 2013 Apr; 92(4):614-20. PubMed ID: 23541342
[TBL] [Abstract][Full Text] [Related]
13. Contribution of a mitochondrial tyrosyl-tRNA synthetase mutation to the phenotypic expression of the deafness-associated tRNA
Fan W; Zheng J; Kong W; Cui L; Aishanjiang M; Yi Q; Wang M; Cang X; Tang X; Chen Y; Mo JQ; Sondheimer N; Ge W; Guan MX
J Biol Chem; 2019 Dec; 294(50):19292-19305. PubMed ID: 31685661
[TBL] [Abstract][Full Text] [Related]
14. A novel homozygous YARS2 mutation causes severe myopathy, lactic acidosis, and sideroblastic anemia 2.
Nakajima J; Eminoglu TF; Vatansever G; Nakashima M; Tsurusaki Y; Saitsu H; Kawashima H; Matsumoto N; Miyake N
J Hum Genet; 2014 Apr; 59(4):229-32. PubMed ID: 24430573
[TBL] [Abstract][Full Text] [Related]
15. YARS as an oncogenic protein that promotes gastric cancer progression through activating PI3K-Akt signaling.
Zhang C; Lin X; Zhao Q; Wang Y; Jiang F; Ji C; Li Y; Gao J; Li J; Shen L
J Cancer Res Clin Oncol; 2020 Feb; 146(2):329-342. PubMed ID: 31912229
[TBL] [Abstract][Full Text] [Related]
16. Loss of function mutations in VARS encoding cytoplasmic valyl-tRNA synthetase cause microcephaly, seizures, and progressive cerebral atrophy.
Stephen J; Nampoothiri S; Banerjee A; Tolman NJ; Penninger JM; Elling U; Agu CA; Burke JD; Devadathan K; Kannan R; Huang Y; Steinbach PJ; Martinis SA; Gahl WA; Malicdan MCV
Hum Genet; 2018 Apr; 137(4):293-303. PubMed ID: 29691655
[TBL] [Abstract][Full Text] [Related]
17. An assessment of mechanisms underlying peripheral axonal degeneration caused by aminoacyl-tRNA synthetase mutations.
Stum M; McLaughlin HM; Kleinbrink EL; Miers KE; Ackerman SL; Seburn KL; Antonellis A; Burgess RW
Mol Cell Neurosci; 2011 Feb; 46(2):432-43. PubMed ID: 21115117
[TBL] [Abstract][Full Text] [Related]
18. Expanding the clinical phenotype of IARS2-related mitochondrial disease.
Vona B; Maroofian R; Bellacchio E; Najafi M; Thompson K; Alahmad A; He L; Ahangari N; Rad A; Shahrokhzadeh S; Bahena P; Mittag F; Traub F; Movaffagh J; Amiri N; Doosti M; Boostani R; Shirzadeh E; Haaf T; Diodato D; Schmidts M; Taylor RW; Karimiani EG
BMC Med Genet; 2018 Nov; 19(1):196. PubMed ID: 30419932
[TBL] [Abstract][Full Text] [Related]
19. Compound heterozygosity for loss-of-function FARSB variants in a patient with classic features of recessive aminoacyl-tRNA synthetase-related disease.
Antonellis A; Oprescu SN; Griffin LB; Heider A; Amalfitano A; Innis JW
Hum Mutat; 2018 Jun; 39(6):834-840. PubMed ID: 29573043
[TBL] [Abstract][Full Text] [Related]
20. De Novo and Bi-allelic Pathogenic Variants in NARS1 Cause Neurodevelopmental Delay Due to Toxic Gain-of-Function and Partial Loss-of-Function Effects.
Manole A; Efthymiou S; O'Connor E; Mendes MI; Jennings M; Maroofian R; Davagnanam I; Mankad K; Lopez MR; Salpietro V; Harripaul R; Badalato L; Walia J; Francklyn CS; Athanasiou-Fragkouli A; Sullivan R; Desai S; Baranano K; Zafar F; Rana N; Ilyas M; Horga A; Kara M; Mattioli F; Goldenberg A; Griffin H; Piton A; Henderson LB; Kara B; Aslanger AD; Raaphorst J; Pfundt R; Portier R; Shinawi M; Kirby A; Christensen KM; Wang L; Rosti RO; Paracha SA; Sarwar MT; Jenkins D; ; Ahmed J; Santoni FA; Ranza E; Iwaszkiewicz J; Cytrynbaum C; Weksberg R; Wentzensen IM; Guillen Sacoto MJ; Si Y; Telegrafi A; Andrews MV; Baldridge D; Gabriel H; Mohr J; Oehl-Jaschkowitz B; Debard S; Senger B; Fischer F; van Ravenwaaij C; Fock AJM; Stevens SJC; Bähler J; Nasar A; Mantovani JF; Manzur A; Sarkozy A; Smith DEC; Salomons GS; Ahmed ZM; Riazuddin S; Riazuddin S; Usmani MA; Seibt A; Ansar M; Antonarakis SE; Vincent JB; Ayub M; Grimmel M; Jelsig AM; Hjortshøj TD; Karstensen HG; Hummel M; Haack TB; Jamshidi Y; Distelmaier F; Horvath R; Gleeson JG; Becker H; Mandel JL; Koolen DA; Houlden H
Am J Hum Genet; 2020 Aug; 107(2):311-324. PubMed ID: 32738225
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
